Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, China.
Hunan Province Key Laboratory in Neurodegenerative Disorders, Central South University, Changsha 410008, China.
Sci Rep. 2016 Sep 8;6:32478. doi: 10.1038/srep32478.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons of the brain, brainstem and spinal cord. To date, mutations in more than 30 genes have been linked to the pathogenesis of ALS. Among them, SOD1, FUS and TARDBP are ranked as the three most common genes associated with ALS. However, no mutation analysis has been reported in central-southern China. In this study, we sequenced SOD1, FUS and TARDBP in a central-southern Chinese cohort of 173 patients with ALS (15 familial ALS and 158 sporadic ALS) to detect mutations. As a result, five missense mutations in SOD1, namely, p.D101N, p.D101G, p.C111Y, p.N86S and p.V87A, were identified in three unrelated familial probands and three sporadic cases; two mutations in FUS were found in two unrelated familial probands, including an insertion mutation (p.P525_Y526insY) and a missense mutation (p.R521H); no variants of TARDBP were observed in patients. Therefore, SOD1 mutations were present in 20.0% of familial ALS patients and 1.9% of sporadic ALS patients, while FUS mutations were responsible for 13.3% of familial ALS cases, and TARDBP mutations were rare in either familial or sporadic ALS cases. This study broadens the known mutational spectrum in patients with ALS and further demonstrates the necessity for genetic screening in ALS patients from central-southern China.
肌萎缩侧索硬化症(ALS)是一种致命的神经退行性疾病,影响大脑、脑干和脊髓的运动神经元。迄今为止,已有 30 多个基因突变与 ALS 的发病机制有关。其中,SOD1、FUS 和 TARDBP 被列为与 ALS 最相关的三个常见基因。然而,在中国中南部地区尚未报道过突变分析。在这项研究中,我们对 173 名中国中南部 ALS 患者(15 名家族性 ALS 和 158 名散发性 ALS)的 SOD1、FUS 和 TARDBP 进行了测序,以检测突变。结果,在三个无关联的家族性先证者和三个散发性病例中发现了 SOD1 中的五个错义突变,即 p.D101N、p.D101G、p.C111Y、p.N86S 和 p.V87A;在两个无关联的家族性先证者中发现了 FUS 的两个突变,包括插入突变(p.P525_Y526insY)和错义突变(p.R521H);在患者中未观察到 TARDBP 的变异。因此,SOD1 突变存在于 20.0%的家族性 ALS 患者和 1.9%的散发性 ALS 患者中,而 FUS 突变导致 13.3%的家族性 ALS 病例,TARDBP 突变在家族性或散发性 ALS 病例中均罕见。这项研究拓宽了 ALS 患者已知的突变谱,并进一步证明了在中国中南部地区对 ALS 患者进行基因筛查的必要性。